Search Results 621-630 of 17338 for treatment resistant depression

  1. AMT-260 Gene Therapy Study in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy - Mayo Clinic

    This is a study of AMT-260 in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy (MTLE). It is designed to investigate the Safety, Tolerability, ...

  2. National Alliance on Mental Illness Archives - Mayo Clinic News Network

    thinking and behavior. Examples of mental illness include depression, anxiety disorders, schizophrenia, eating disorders and addictive behaviors. In May, NAMI ...

  3. Medical Research & Education - Mayo Clinic News Network

    ... treatment resistance can lead to new hope for some featured. Cancer. Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some.

  4. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    Clinical Trials · Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors · More about research at Mayo Clinic · Mayo ...

  5. Voriconazole (oral route) - Side effects & dosage - Mayo Clinic

    It may also be used to treat patients with serious fungal or yeast infections who cannot tolerate or do not respond to other types of treatment. This medicine ...

  6. Sharing Mayo Clinic: Now seizure free, epilepsy patient wants to share her music

    Despite medication, Destiny's seizures continued ... "I had dizziness, drowsiness, depression, anger ... drug-resistant epilepsy," Dr. Feyissa says ...

  7. Testing Whether The Addition Of Carboplatin Chemotherapy To Cabazitaxel Chemotherapy Will Improve Outcomes Compared To Cabazitaxel Alone In People With Castrate-Resistant Prostate Cancer That Has Spread Beyond The Prostate To Other Parts Of The Body - Mayo Clinic

    Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.

  8. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...

  9. Medical Research & Education - Mayo Clinic News Network

    ... treatment resistance can lead to new hope for some featured. Cancer. Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some.

  10. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma · More about research at Mayo ...